Registry of Lobbyists
Total Number of Communication Reports: 14
Monthly communication reports in the last 6 months: 0
| Subject matters | Details | Categories |
|---|---|---|
|
Budget, Health, Industry
|
Engagement with officials on issues related to the National Strategy for Rare Disease Drugs, and other policies or programs related to rare diseases.
|
Policies or Program
|
|
Budget, Health
|
Federally-funded public drug plans, with respect to reimbursement for drug products for federal plan beneficiaries.
|
Policies or Program
|
|
Budget, Health, Industry
|
Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals including any health technology assessment-related or other policy discussions that might involve Health Canada and its ongoing relationship with Canada's Drug Agency and/or other pan-Canadian health organizations.
|
Policies or Program
|
|
Budget, Health, Industry
|
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board
|
Policies or Program
|
|
Budget, Health, Industry, Research and Development, Science and Technology
|
Innovation, Science and Economic Development Canada regarding the Innovation and Skills Agenda, the Biomanufacturing and Life Sciences Strategy and other government policies and programs related to incenting research and development activities in Canada.
|
Policies or Program
|
|
Budget, Health, Industry
|
National pharmacare, with a particular focus on access to medicines and rare disease and orphan drug policies
|
Policies or Program
|
|
Health
|
Regulatory amendments and/or guidelines and/or policies related to the Food and Drugs Act and Health Canada's review of medicines (particularly rare disease treatments).
|
Regulation, Policies or Program
|
Address:
PO Box 81062
Ottawa, ON K1P 1B1
Canada
Telephone number:
613-800-8340
Bob McLay, Chair
RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares is not a subsidiary of any other parent companies.
The activities of RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
GERALD JEFFCOTT | Public offices held
Firm: 3Sixty Public Affairs